Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · IEX Real-Time Price · USD
5.75
-0.03 (-0.52%)
At close: Jul 19, 2024, 4:00 PM
5.67
-0.08 (-1.39%)
Pre-market: Jul 20, 2024, 9:27 AM EDT
BDTX Market Cap
BDTX has a market cap or net worth of $323.45 million as of July 22, 2024. Its market cap has increased by 97.71% in one year.
Market Cap
323.45M
Enterprise Value
228.80M
1-Year Change
97.71%
Ranking
Category
Stock Price
$5.75
Market Cap Chart
Since January 30, 2020, BDTX's market cap has decreased from $1.29B to $323.45M, a decrease of -74.90%. That is a compound annual growth rate of -26.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 323.50M | 122.95% |
| Dec 29, 2023 | 145.10M | 121.53% |
| Dec 30, 2022 | 65.50M | -66.08% |
| Dec 31, 2021 | 193.10M | -83.26% |
| Dec 31, 2020 | 1.15B | -10.46% |
| Jan 30, 2020 | 1.29B | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inozyme Pharma | 329.69M |
| Nautilus Biotechnology | 326.94M |
| XOMA Corporation | 326.58M |
| Foghorn Therapeutics | 326.44M |
| Spok Holdings | 325.55M |
| Amarin Corporation | 322.35M |
| Zynex | 320.93M |
| ALX Oncology Holdings | 320.42M |